Skip to content
Search jobs inside your AI agent. Claude, ChatGPT, Claude Code, Codex, Gemini, Cursor and Grok
Connect

zealandpharma

Zealand Pharma is a Danish biotechnology company focused on discovering, designing, and developing peptide-based medicines for metabolic diseases, with particular emphasis on obesity and metabolic health treatments.

H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.Denmark Fast-track company — This company is certified by SIRI for the Danish Fast-track scheme for hiring foreign skilled workers. The certification belongs to the employer and is not a commitment to sponsor this role.

Correct zealandpharma

zealandpharma is…

Company facts

Founded
1998
Headquarters
Denmark
CEO
Adam Steensberg

About

Zealand Pharma is a Danish biotechnology company headquartered in Copenhagen, Denmark, with additional operations in Boston, Massachusetts. The company is dedicated to the discovery, design, and development of innovative peptide-based medicines for people who need them. With a focus on metabolic diseases, Zealand Pharma is advancing a differentiated clinical pipeline with a strong emphasis on obesity and metabolic health. The company has built a robust platform of peptide expertise and has advanced more than 10 drug candidates through its innovative research. Zealand Pharma is publicly traded on Nasdaq under the ticker symbol ZEAL. The company operates at the forefront of peptide drug development, combining deep scientific expertise with a commitment to creating life-changing therapeutics. Through strategic expansion - including establishing new research units in Cambridge, Massachusetts - Zealand Pharma is strengthening its global R&D capabilities to deliver transformative medicines for people living with metabolic diseases.

Open positions

20 jobs